Bicycle Therapeutics(BCYC) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results Multiple preclinical and clinical abstracts accepted for presentation at 2024 ASCO Annual Meeting and AACR Annual Meeting underscore breadth of Bicycle platform technology and pipeline Continued progress across research and development (R&D) pipeline, with numerous clinical data readouts and updates expected in 2H 2024 Mike Hannay, D.Sc., FRPharmS, promoted to Chief Product and Supply Chain Of icer Ca ...